This morning most investors are going to be looking into those stocks which managed to record significant gains last Friday and one of the stocks worth looking into is that of Grow Life Tech Corp (OTCMKTS:GLWLF).
On Thursday , GLWLF stock soared 33.24% to $0.2333 with more than 162 shares, compared to its average volume of 1.3k shares. The stock has moved within a range of $0.2333 – 0.2333 after opening trade at $0.2333.
Commencement of Clinical Study of Artemic Support Featuring MyCell Technology on Patients with Long COVID
The biotech innovator came into sharp focus last Friday after it announced that it was co-sponsoring a study related to Artemic Support, one of its proprietary natural health products. The news came as a source of significant optimism among investors and the Grow Life Tech stock soared by as much as 44% to emerge as one of the major gainers.
In this study, the company is going to look into the effect the product can have in people who may be suffering from Long COVID syndrome. At this point in time, it is a case of concern in many parts of the world and hence, the study could prove to be an important one for the company.
There is a significant number of symptoms that COVID patients can experience for as many as five weeks since getting infected by the virus. The rally in the Grow Life Tech stock is an indication of the fact that investors are quite bullish about the possibilities of this study.
“I’m excited about the “First Patient In” on December 13, as I’m expecting highly valuable results on the safety and efficacy of Artemic Support®, based on its breakthrough MyCell technology, and the potential benefit for millions of people suffering from Long COVID, who have had no therapeutic options so far,” said the study organizer Dr. Dieter L. Russmann MD, Senator h.c., from Swiss PharmaCan.